Polypharmacy: As a Predictive Indicator of Mortality and Length of Stay for Geriatric Patients Charged in ICU

Belice, Tahir; Demir, İsmail

doi:10.14744/ejmi.2020.51084

Polypharmacy: As a Predictive Indicator of Mortality and Length of Stay for Geriatric Patients Charged in ICU

İsmail DEMİR, (Sağlık Bilimleri Üniversitesi, İzmir Bozyaka Eğitim ve Araştırma Hastanesi, İç Hastalıkları Kliniği, İzmir, Türkiye)

Tahir BELİCE (Sağlık Bilimleri Üniversitesi, İzmir Bozyaka Eğitim ve Araştırma Hastanesi, İç Hastalıkları Kliniği, İzmir, Türkiye)

Eurasian Journal of Medical Investigation

1 0

Yıl: 2020 Cilt: 4 Sayı: 3 Sayfa Aralığı: 315 - 319 Metin Dili: İngilizce DOI: 10.14744/ejmi.2020.51084 İndeks Tarihi: 02-11-2020

Polypharmacy: As a Predictive Indicator of Mortality and Length of Stay for Geriatric Patients Charged in ICU

Öz:

Objectives: In this study, we aimed at evaluating the effect of polypharmacy on the mortality and the length of stay ofelderly patients that charged in the ICU.Methods: The patients aged 65 and over which were admitted to the intensive care unit between the dates of September 2018 and August 2019 were included in this study. The statistical calculations were made with SPSS and then thesignificant parameters were investigated seperately.Results: In ICU, retrospectively, a positive statistical significance was found between polypharmacy and the lenght ofstay with mortality rates in our study with 235 geriatric patients (p<0.05). When biochemical parameters were compared between polypharmacy and non-polypharmacy groups, a significant difference was found in RDW, vitamin B12,uric acid, Fe and ferritin parameters (p<0.05).Conclusion: If we could make comprehensive geriatric assessments in time, we would be able to make the right diagnosis and the right choices of medication for older people and as a result we would be able to decrease the proportionof negative effects of polypharmacy to some extent.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Bibliyografik

1. Nguyen YL, Angus DC, Boumendil A, Guidet B, The challenge of admitting the very elderly to intensive care. Ann Intensive Care 2011;1:29.
2. Fowler RA, Adhikari NK, Bhagwanjee S Clinical review: critical care in the global context—disparities in burden of illness, access, and economics. Crit Care 2008;12:225.
3. US Census Bureau. Population Projections of the United States by Age, Sex, Race, Hispanic Origin and Nativity: 1999–2100. Available Internet access (16.032020): https://www.census. gov/library/working-papers/2002/demo/POP-twps0067.html
4. Chelluri L, Pinsky MR, Donahoe MP, Grenvik A, Long-term outcome of critically ill elderly patients requiring intensive care. JAMA 1993;269:3119–3123.
5. Karaveli A, Cerit G.N, Özyurt E, Evaluation Of Admission Causes And Mortality Rates Of 65 Years Of Age And Older Patients Admitted From The Emergency Department To The Intensive Care Unit Turkish Journal of Geriatrics 2018;21:515–521.
6. Toptas M, Samanci N.S, Akkoc E, Yucetas E, Cebeci E, Sen O, et al. Factors Affecting the Length of Stay in the Intensive Care Unit: Our Clinical Experience, Hindawi BioMed Research International Volume 2018, Article ID 9438046.
7. Wood KA, Ely EW. What does it mean to be critically ill and elderly? Curr Opin Crit Care 2003;9:316–320.
8. De Rooij SE, Govers A, Korevaar JC, Abu-Hanna A, Levi M, de Jonge E, Short-term and long-term mortality in very elderly patients admitted to an intensive care unit. Intensive Care Med 2006;32:1039–1044.
9. Veehof L, Stewart R, Haaijer-Ruskamp F, Jong BM. The development of polypharmacy. A longitudinal study. Fam Pract 2000;17:261–7.
10. United Kingdom Department of Health. Medicines and older people: implementing medicines-related aspects of the The National Service of Framework (NSF) for older people. 2001. Available Internet access (16.032020): https://assets.publishing.service.gov.uk/government/uploads/system/uploads/ attachment_data/file/198033/National_Service_Framework_ for_Older_People.pdf
11. Fillit HM, Futterman R, Orland BI, Chim T, Susnow L, Picariello GP, et al. Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews. Am J Manag Care 1999;5:587–94.
12. Hajjar ER, Hanlon JT, Sloane RJ, Lindblad CI, Pieper CF, Ruby CM, et al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc 2005;53:1518–23.
13. Gamble J-M, Hall JJ, Marrie TJ, Sadowski CA, Majumdar SR, Eurich DT. Medication transitions and polypharmacy in older adults following acute care. Ther Clin Risk Manag 2014;10:189– 96.
14. Hanlon JT, Artz MB, Pieper CF, Lindblad CI, Sloane RJ, Ruby CM, et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother 2004;38:9–14.
15. Schmader K, Hanlon J, Weinberger M, Landsman PB, Samsa GP, Lewis I, et al. Appropriateness of medication prescribing in ambulatory elderly patients. J Am Geriatr Soc 1994;42:1241–7.
16. Ray S, Bhattacharyya M, Pramanik J, Todi S. Drug-drug interactions in the ICU. Crit Care. 2009;13(Suppl 1):P495.
17. Leelakanok N, Holcombe AL, Lund BC, Gu X, Schweizer ML. Association between polypharmacy and death: A systematic review and meta-analysis. J Am Pharm Assoc (2003). 2017;57:729–738.e10.
18. Zaal IJ, Devlin JW, Peelen LM, Slooter AJ. A systematic review of risk factors for delirium in the ICU. Crit Care Med 2015;43:40–7.
19. Pauley E, Lishmanov A, Schumann S, Gala GJ, van Diepen S, Katz JN. Delirium is a robust predictor of morbidity and mortality among critically ill patients treated in the cardiac intensive care unit. Am Heart J 2015;170:79–86,86.e1.
20. Braune S, Gurlit S. Prevention of delirium in the intensive care unit. Dtsch Med Wochenschr 2019;144:1611–1618.
21. Jyrkkä J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging 2009;26:1039–48.
22. Bell CM, Brener SS, Gunraj N, Huo C, Bierman AS, Scales DC, et al. Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA 2011;306:840–7.
23. Budnitz DS, Pollock DA, Weidenbach KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006;296:1858–66.
24. Mortazavi SS, Shati M, Keshtkar A, Malakouti SK, Bazargan M, Assari S. Defining polypharmacy in the elderly: a systematic review protocol. BMJ Open 2016;6:e010989.
25. Rochon PA, Gurwitz JH. The prescribing cascade revisited. Lancet 2017;389:1778–80.
26. Moitra VK, Guerra C, Linde-Zwirble WT, Wunsch H. Relationship Between ICU Length of Stay and Long-Term Mortality for Elderly ICU Survivors. Crit Care Med 2016;44:655–62.
27. Nobili, A Licata G, Salerno F, Pasina L, Tettamanti M, Mannucci P. M, Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. European Journal of Clinical Pharmacology 2011;67:507–19.
28. Dalton K, Byrne S, Role of the pharmacist in reducing healthcare costs: current insights. Integr Pharm Res Pract 2017 Jan 25;6:37–46.

APA	Demir İ, Belice T (2020). Polypharmacy: As a Predictive Indicator of Mortality and Length of Stay for Geriatric Patients Charged in ICU. , 315 - 319. 10.14744/ejmi.2020.51084
Chicago	Demir İsmail,Belice Tahir Polypharmacy: As a Predictive Indicator of Mortality and Length of Stay for Geriatric Patients Charged in ICU. (2020): 315 - 319. 10.14744/ejmi.2020.51084
MLA	Demir İsmail,Belice Tahir Polypharmacy: As a Predictive Indicator of Mortality and Length of Stay for Geriatric Patients Charged in ICU. , 2020, ss.315 - 319. 10.14744/ejmi.2020.51084
AMA	Demir İ,Belice T Polypharmacy: As a Predictive Indicator of Mortality and Length of Stay for Geriatric Patients Charged in ICU. . 2020; 315 - 319. 10.14744/ejmi.2020.51084
Vancouver	Demir İ,Belice T Polypharmacy: As a Predictive Indicator of Mortality and Length of Stay for Geriatric Patients Charged in ICU. . 2020; 315 - 319. 10.14744/ejmi.2020.51084
IEEE	Demir İ,Belice T "Polypharmacy: As a Predictive Indicator of Mortality and Length of Stay for Geriatric Patients Charged in ICU." , ss.315 - 319, 2020. 10.14744/ejmi.2020.51084
ISNAD	Demir, İsmail - Belice, Tahir. "Polypharmacy: As a Predictive Indicator of Mortality and Length of Stay for Geriatric Patients Charged in ICU". (2020), 315-319. https://doi.org/10.14744/ejmi.2020.51084

APA	Demir İ, Belice T (2020). Polypharmacy: As a Predictive Indicator of Mortality and Length of Stay for Geriatric Patients Charged in ICU. Eurasian Journal of Medical Investigation, 4(3), 315 - 319. 10.14744/ejmi.2020.51084
Chicago	Demir İsmail,Belice Tahir Polypharmacy: As a Predictive Indicator of Mortality and Length of Stay for Geriatric Patients Charged in ICU. Eurasian Journal of Medical Investigation 4, no.3 (2020): 315 - 319. 10.14744/ejmi.2020.51084
MLA	Demir İsmail,Belice Tahir Polypharmacy: As a Predictive Indicator of Mortality and Length of Stay for Geriatric Patients Charged in ICU. Eurasian Journal of Medical Investigation, vol.4, no.3, 2020, ss.315 - 319. 10.14744/ejmi.2020.51084
AMA	Demir İ,Belice T Polypharmacy: As a Predictive Indicator of Mortality and Length of Stay for Geriatric Patients Charged in ICU. Eurasian Journal of Medical Investigation. 2020; 4(3): 315 - 319. 10.14744/ejmi.2020.51084
Vancouver	Demir İ,Belice T Polypharmacy: As a Predictive Indicator of Mortality and Length of Stay for Geriatric Patients Charged in ICU. Eurasian Journal of Medical Investigation. 2020; 4(3): 315 - 319. 10.14744/ejmi.2020.51084
IEEE	Demir İ,Belice T "Polypharmacy: As a Predictive Indicator of Mortality and Length of Stay for Geriatric Patients Charged in ICU." Eurasian Journal of Medical Investigation, 4, ss.315 - 319, 2020. 10.14744/ejmi.2020.51084
ISNAD	Demir, İsmail - Belice, Tahir. "Polypharmacy: As a Predictive Indicator of Mortality and Length of Stay for Geriatric Patients Charged in ICU". Eurasian Journal of Medical Investigation 4/3 (2020), 315-319. https://doi.org/10.14744/ejmi.2020.51084